These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15981203)

  • 1. Correlation of DNA damage in epidemic dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice.
    Das M; Ansari KM; Dhawan A; Shukla Y; Khanna SK
    Int J Cancer; 2005 Dec; 117(5):709-17. PubMed ID: 15981203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice.
    Ansari KM; Dhawan A; Khanna SK; Das M
    Food Chem Toxicol; 2005 Jan; 43(1):147-53. PubMed ID: 15582207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of bioantioxidants on argemone oil/sanguinarine alkaloid induced genotoxicity in mice.
    Ansari KM; Dhawan A; Khanna SK; Das M
    Cancer Lett; 2006 Nov; 244(1):109-18. PubMed ID: 16458423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin tumor promotion by argemone oil/alkaloid in mice: evidence for enhanced cell proliferation, ornithine decarboxylase, cyclooxygenase-2 and activation of MAPK/NF-kappaB pathway.
    Ansari KM; Das M
    Food Chem Toxicol; 2010 Jan; 48(1):132-8. PubMed ID: 19796664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of tumour promotion by topical application of argemone oil/isolated sanguinarine alkaloid in a model of mouse skin carcinogenesis.
    Ansari KM; Das M
    Chem Biol Interact; 2010 Dec; 188(3):591-7. PubMed ID: 20691676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil.
    Das M; Khanna SK
    Crit Rev Toxicol; 1997 May; 27(3):273-97. PubMed ID: 9189656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unequivocal evidence of genotoxic potential of argemone oil in mice.
    Ansari KM; Chauhan LK; Dhawan A; Khanna SK; Das M
    Int J Cancer; 2004 Dec; 112(5):890-5. PubMed ID: 15386392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the risk of epidemic dropsy from black salve use.
    Croaker A; King GJ; Pyne JH; Anoopkumar-Dukie S; Liu L
    J Appl Toxicol; 2018 Oct; 38(10):1274-1281. PubMed ID: 29603306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of topical application of α-tocopherol and/or N-acetyl cysteine on argemone oil/alkaloid-induced skin tumorigenesis in mice.
    Pal A; Alam S; Singhal J; Kumar R; Ansari KM; Das M
    Nutr Cancer; 2013; 65 Suppl 1():78-87. PubMed ID: 23682786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of argemone oil and argemone alkaloid, sanguinarine on Sertoli-germ cell coculture.
    Mishra V; Saxena DK; Das M
    Toxicol Lett; 2009 Apr; 186(2):104-10. PubMed ID: 19429230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edible oil adulterants, argemone oil and butter yellow, as aetiological factors for gall bladder cancer.
    Mishra V; Mishra M; Ansari KM; Chaudhari BP; Khanna R; Das M
    Eur J Cancer; 2012 Sep; 48(13):2075-85. PubMed ID: 22071130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety evaluation studies on argemone oil through dietary exposure for 90days in rats.
    Babu ChK; Khanna SK; Das M
    Food Chem Toxicol; 2006 Jul; 44(7):1151-7. PubMed ID: 16554115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemic dropsy following transcutaneous absorption of Argemone mexicana oil.
    Sood NN; Sachdev MS; Mohan M; Gupta SK; Sachdev HP
    Trans R Soc Trop Med Hyg; 1985; 79(4):510-2. PubMed ID: 4082260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of carcinogenic potential of repeated fish fried oil in mice.
    Pandey MK; Das M
    Mol Carcinog; 2006 Oct; 45(10):741-51. PubMed ID: 16683249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oxidative stress in some cases of argimone oil poisoning during a recent outbreak of epidemic dropsy in India.
    Banerjee BD; Seth V; Koner BC; Ahmed RS; Sharma M; Grover SS; Rautala RS; Avasthi R; Pasha ST
    Int J Environ Health Res; 2000 Dec; 10(4):341-6. PubMed ID: 11260782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report of a small outbreak of epidemic dropsy.
    Dhayal GL; Agarwal H; Mathur A; Mathur S; Kishoria N; Jain S; Choudhary R; Sharma R; Bishnoi S; Mathur S
    J Indian Med Assoc; 2013 Mar; 111(3):200-1. PubMed ID: 24592766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argemone oil, sanguinarine, and epidemic-dropsy glaucoma.
    HAKIM SA
    Br J Ophthalmol; 1954 Apr; 38(4):193-216. PubMed ID: 13149763
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemic dropsy in Trans Yamuma areas of Delhi and U.P.
    Gomber S; Daral TS; Sharma PP; Faridi MM
    Indian Pediatr; 1994 Jun; 31(6):671-4. PubMed ID: 7896391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argemone mexicana and epidemic dropsy: phytopharmacology and putative sequelae and therapy.
    Vaidya AD; Pandita N; Godse C; Meshram M
    J Assoc Physicians India; 2001 Oct; 49():1041-2. PubMed ID: 11848317
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory investigation of epidemic dropsy in Addis Ababa, Ethiopia.
    Assefa A; Teka F; Guta M; Melaku D; Naser E; Tesfaye B; Messele T; Kebede A; Getachew M; Mudi K; Alebachew A; Azazh A; Bane A; Seboxa T; Girma S; Muzein R; Urga K
    Ethiop Med J; 2013 Oct; Suppl 2():21-32. PubMed ID: 24654506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.